Preparation and Evaluation of Icariside Ii-Loaded Binary Mixed Micelles Using Solutol Hs15 and Pluronic F127 As Carriers

Jian Hou,Jing Wang,E. Sun,Lei Yang,Hong-Mei Yan,Xiao-Bin Jia,Zhen-Hai Zhang
DOI: https://doi.org/10.3109/10717544.2016.1167270
IF: 6.819
2016-01-01
Drug Delivery
Abstract:An effective anti-cancer drug, icariside II (IS), has been used to treat a variety of cancers in vitro. However, its poor aqueous solubility and permeability lead to low oral bioavailability. The aim of this work was to use Solutol (R) HS15 and Pluronic F127 as surfactants to develop novel mixed micelles to enhance the oral bioavailability of IS by improving permeability and inhibiting efflux. The IS-loaded mixed micelles were prepared using the method of ethanol thin-film hydration. The physicochemical properties, dissolution property, oral bioavailability of the male SD rats, permeability and efflux of Caco-2 transport models, and gastrointestinal safety of the mixed micelles were evaluated. The optimized IS-loaded mixed micelles showed that at 4:1 ratio of Solutol (R) HS15 and Pluronic F127, the particle size was 12.88nm with an acceptable polydispersity index of 0.172. Entrapment efficiency (94.6%) and drug loading (9.7%) contributed to the high solubility (11.7mg/mL in water) of IS, which increased about 900-fold. The SF-IS mixed micelle release profile showed a better sustained release property than that of IS. In Caco-2 cell monolayer models, the efflux ratio dramatically decreased by 83.5%, and the relative bioavailability of the mixed micelles (AUC(0-)) compared with that of IS (AUC(0-)) was 317%, indicating potential for clinical application. In addition, a gastrointestinal safety assay also provided reliable clinical evidence for the safe use of this micelle.
What problem does this paper attempt to address?